Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Neurology. Clinical Practice|September 12, 2025
Atypical Psychosis in Parkinson Disease: A Retrospective Study on 24-Hour Continuous Subcutaneous Infusion of Foslevodopa/FoscarbidopaLindun Ge, Yasuyoshi Kimura, Keita Kakuda, et al.
Pharmacology Research & Perspectives|January 30, 2024
Decreased hepatic enzymes reflect the decreased vitamin B6 levels in Parkinson's disease patientsKensuke Ikenaka, Yuta Kajiyama, César Aguirre, et al.
Bioorganic & Medicinal Chemistry|November 29, 2015
Modification of a dihydropyrrolopyrimidine phosphoinositide 3-kinase (PI3K) inhibitor to improve oral bioavailabilityHatsuo Kawada, Hirosato Ebiike, Masao Tsukazaki, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799Jun Ohwada, Hirosato Ebiike, Hatsuo Kawada, et al.
Journal of Neuroinflammation|August 7, 2019
Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in JapaneseKotaro Ogawa, Tatsusada Okuno, Kazuyoshi Hosomichi, et al.
Journal of Dermatological Science|April 10, 2021
Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypesToshihiro Kishikawa, Noriko Arase, Shigeyoshi Tsuji, et al.
Nature Communications|November 19, 2016
Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidismTatsuya Tamura, Hiroshi Noda, Eri Joyashiki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 19, 2024
New Insights into Freezing of Gait in Parkinson's Disease from Spectral Dynamic Causal ModelingSeira Taniguchi, Yuta Kajiyama, Takanori Kochiyama, et al.
Pageof 6